Woebot Health, founded in 2017 and headquartered in the United States, has carved a niche as a pioneer in the AI-driven mental health and wellness sector. Positioning itself as "the world’s first mental health ally for people and businesses," it offers scalable, engaging AI solutions tailored for both individual and corporate entities.
Operating within the intersecting realms of AI, Digital Health, and Health and Wellness, Woebot Health continues to redefine how mental well-being is approached, moving beyond traditional methodologies to leverage cutting-edge technology.
The company’s progressive trajectory is evidenced by a recent $9.50M Late VC investment in March 2022, backed by Leaps by Bayer. This financial endorsement from a noteworthy investor underscores the market's confidence in Woebot Health's innovative approach and its potential to transform the mental health landscape.